Skip to content

TENAX THERAPEUTICS, INC.

TENX

CIK 0000034956

← back to feed
Revenue (TTM)
$0
Q1 May 2026
Net Income (TTM)
−$52.78M
−198.8% YoY Q1 May 2026
EPS Diluted (TTM)
−$1.30
−16.5% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$23.17M
Q1 May 2026
Cash
$118.8M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
26.53M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings